Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment.
- Published In:
- European journal of nuclear medicine and molecular imaging, 52(10), 3891-3902 (2025)
- Authors:
- Li, Xiaochen, Liu, Yang(4), Zhang, Zizhen, Hai, Wangxi, Pan, Yu, Zhang, Yifan
- Database ID:
- RPEP-12113
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12113APA
Li, Xiaochen; Liu, Yang; Zhang, Zizhen; Hai, Wangxi; Pan, Yu; Zhang, Yifan. (2025). Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment.. European journal of nuclear medicine and molecular imaging, 52(10), 3891-3902. https://doi.org/10.1007/s00259-025-07197-z
MLA
Li, Xiaochen, et al. "Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment.." European journal of nuclear medicine and molecular imaging, 2025. https://doi.org/10.1007/s00259-025-07197-z
RethinkPeptides
RethinkPeptides Research Database. "Exendin-4 imaging based on gastrointestinal GLP-1R targets f..." RPEP-12113. Retrieved from https://rethinkpeptides.com/research/li-2025-exendin4-imaging-based-on
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.